These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Discovery of monocarbonyl curcumin-BTP hybrids as STAT3 inhibitors for drug-sensitive and drug-resistant breast cancer therapy. Zhang W; Guo J; Li S; Ma T; Xu D; Han C; Liu F; Yu W; Kong L Sci Rep; 2017 Apr; 7():46352. PubMed ID: 28397855 [TBL] [Abstract][Full Text] [Related]
4. T63, a new 4-arylidene curcumin analogue, induces cell cycle arrest and apoptosis through activation of the reactive oxygen species-FOXO3a pathway in lung cancer cells. Liu H; Zhou BH; Qiu X; Wang HS; Zhang F; Fang R; Wang XF; Cai SH; Du J; Bu XZ Free Radic Biol Med; 2012 Dec; 53(12):2204-17. PubMed ID: 23085518 [TBL] [Abstract][Full Text] [Related]
5. Curcuminoid B63 induces ROS-mediated paraptosis-like cell death by targeting TrxR1 in gastric cells. Chen X; Chen X; Zhang X; Wang L; Cao P; Rajamanickam V; Wu C; Zhou H; Cai Y; Liang G; Wang Y Redox Biol; 2019 Feb; 21():101061. PubMed ID: 30590310 [TBL] [Abstract][Full Text] [Related]
7. Selective killing of gastric cancer cells by a small molecule targeting ROS-mediated ER stress activation. Zou P; Xia Y; Chen T; Zhang J; Wang Z; Chen W; Chen M; Kanchana K; Yang S; Liang G Mol Carcinog; 2016 Jun; 55(6):1073-86. PubMed ID: 26086416 [TBL] [Abstract][Full Text] [Related]
8. Curcuminoid WZ26, a TrxR1 inhibitor, effectively inhibits colon cancer cell growth and enhances cisplatin-induced cell death through the induction of ROS. Zhang T; Zheng P; Shen X; Shao R; Wang B; Shen H; Zhang J; Xia Y; Zou P Free Radic Biol Med; 2019 Sep; 141():93-102. PubMed ID: 31176737 [TBL] [Abstract][Full Text] [Related]
9. Curcumin derivative WZ35 inhibits tumor cell growth via ROS-YAP-JNK signaling pathway in breast cancer. Wang L; Wang C; Tao Z; Zhao L; Zhu Z; Wu W; He Y; Chen H; Zheng B; Huang X; Yu Y; Yang L; Liang G; Cui R; Chen T J Exp Clin Cancer Res; 2019 Nov; 38(1):460. PubMed ID: 31703744 [TBL] [Abstract][Full Text] [Related]
10. Synthesis and Biological Evaluation of Curcumin-Nitroxide-Based Molecular Hybrids as Antioxidant and Anti-Proliferative Agents. Bognar B; Kuppusamy ML; Madan E; Kalai T; Balog M; Jeko J; Kuppusamy P; Hideg K Med Chem; 2017; 13(8):761-772. PubMed ID: 28530545 [TBL] [Abstract][Full Text] [Related]
11. Synthesis and assessment of the antioxidant and antitumor properties of asymmetric curcumin analogues. Li Q; Chen J; Luo S; Xu J; Huang Q; Liu T Eur J Med Chem; 2015 Mar; 93():461-9. PubMed ID: 25728027 [TBL] [Abstract][Full Text] [Related]
12. Synthesis, characterization and ROS-mediated antitumor effects of palladium(II) complexes of curcuminoids. Li Y; Gu Z; Zhang C; Li S; Zhang L; Zhou G; Wang S; Zhang J Eur J Med Chem; 2018 Jan; 144():662-671. PubMed ID: 29289889 [TBL] [Abstract][Full Text] [Related]
13. Curcumin analog L48H37 induces apoptosis through ROS-mediated endoplasmic reticulum stress and STAT3 pathways in human lung cancer cells. Feng C; Xia Y; Zou P; Shen M; Hu J; Ying S; Pan J; Liu Z; Dai X; Zhuge W; Liang G; Ruan Y Mol Carcinog; 2017 Jul; 56(7):1765-1777. PubMed ID: 28218464 [TBL] [Abstract][Full Text] [Related]
14. Asymmetrical meta-methoxylated diarylpentanoids: Rational design, synthesis and anti-cancer evaluation in-vitro. Leong SW; Chia SL; Abas F; Yusoff K Eur J Med Chem; 2018 Sep; 157():716-728. PubMed ID: 30138803 [TBL] [Abstract][Full Text] [Related]
15. Differential apoptotic and redox regulatory activities of curcumin and its derivatives. Mishra S; Kapoor N; Mubarak Ali A; Pardhasaradhi BV; Kumari AL; Khar A; Misra K Free Radic Biol Med; 2005 May; 38(10):1353-60. PubMed ID: 15855053 [TBL] [Abstract][Full Text] [Related]
16. Curcumin suppresses gastric tumor cell growth via ROS-mediated DNA polymerase γ depletion disrupting cellular bioenergetics. Wang L; Chen X; Du Z; Li G; Chen M; Chen X; Liang G; Chen T J Exp Clin Cancer Res; 2017 Mar; 36(1):47. PubMed ID: 28359291 [TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological evaluation of new curcumin analogues as antioxidant and antitumor agents: molecular modeling study. Bayomi SM; El-Kashef HA; El-Ashmawy MB; Nasr MN; El-Sherbeny MA; Abdel-Aziz NI; El-Sayed MA; Suddek GM; El-Messery SM; Ghaly MA Eur J Med Chem; 2015 Aug; 101():584-94. PubMed ID: 26197162 [TBL] [Abstract][Full Text] [Related]
18. Curcumin potentiates antitumor activity of cisplatin in bladder cancer cell lines via ROS-mediated activation of ERK1/2. Park BH; Lim JE; Jeon HG; Seo SI; Lee HM; Choi HY; Jeon SS; Jeong BC Oncotarget; 2016 Sep; 7(39):63870-63886. PubMed ID: 27564099 [TBL] [Abstract][Full Text] [Related]
19. A novel selective mitochondrial-targeted curcumin analog with remarkable cytotoxicity in glioma cells. Shi L; Gao LL; Cai SZ; Xiong QW; Ma ZR Eur J Med Chem; 2021 Oct; 221():113528. PubMed ID: 34020339 [TBL] [Abstract][Full Text] [Related]
20. Chloro and bromo-pyrazole curcumin Knoevenagel condensates augmented anticancer activity against human cervical cancer cells: design, synthesis, Chaudhary M; Kumar N; Baldi A; Chandra R; Arockia Babu M; Madan J J Biomol Struct Dyn; 2020 Jan; 38(1):200-218. PubMed ID: 30784365 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]